Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Parkinson's Disease

  Free Subscription


01.01.2018

1 BMC Neurol
1 Exp Neurol
1 Int J Neurosci
4 J Neural Transm (Vienna)
1 JAMA
3 Lancet Neurol
6 Mov Disord
1 Nat Neurosci
2 Neurology
3 Neurosci Lett
6 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. PAWLUKOWSKA W, Skonieczna-Zydecka K, Rotter I, Honczarenko K, et al
    The analysis of relationship between selected sociodemografic factors and disorders of speech organs in Parkinson`s patients.
    BMC Neurol. 2017;17:221.
    PubMed     Text format     Abstract available


    Exp Neurol

  2. GALATI S, Song W, Orban G, Luft AR, et al
    Cortical slow wave activity correlates with striatal synaptic strength in normal but not in Parkinsonian rats.
    Exp Neurol. 2017;301.
    PubMed     Text format     Abstract available


    Int J Neurosci

  3. VALLDEORIOLA F, Salvador A, Gomez-Arguelles JM, Marey J, et al
    The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study.
    Int J Neurosci. 2017 Dec 17:1-7. doi: 10.1080/00207454.2017.1387111.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  4. JOMBIK P, Spodniak P, Bahyl V, Necpal J, et al
    Analysis of 3D spatial trajectories in Parkinsonian, essential and physiological tremors.
    J Neural Transm (Vienna). 2017 Dec 28. pii: 10.1007/s00702-017-1835.
    PubMed     Text format     Abstract available

  5. HAMADJIDA A, Nuara SG, Gourdon JC, Huot P, et al
    Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's disease.
    J Neural Transm (Vienna). 2017 Dec 15. pii: 10.1007/s00702-017-1830.
    PubMed     Text format     Abstract available

  6. BARTOSOVA O, Bonnet C, Ulmanova O, Sima M, et al
    Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients.
    J Neural Transm (Vienna). 2017 Dec 19. pii: 10.1007/s00702-017-1829.
    PubMed     Text format     Abstract available

  7. PAGANO G, Niccolini F, Politis M
    The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies.
    J Neural Transm (Vienna). 2017 Dec 20. pii: 10.1007/s00702-017-1823.
    PubMed     Text format     Abstract available


    JAMA

  8. LEES AJ
    From Sgt. Pepper to Dreamachines: My Scientific Odyssey With William S. Burroughs.
    JAMA. 2017;318:2164-2166.
    PubMed     Text format    


    Lancet Neurol

  9. SIMUNI T, Krainc D
    High priority publications on Parkinson's disease in 2017.
    Lancet Neurol. 2018;17:8-10.
    PubMed     Text format    

  10. YPINGA JHL, de Vries NM, Boonen LHHM, Koolman X, et al
    Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data.
    Lancet Neurol. 2017 Dec 12. pii: S1474-4422(17)30406.
    PubMed     Text format     Abstract available

  11. PARASHOS SA
    Parkinson's disease physiotherapy: specialisation adds value.
    Lancet Neurol. 2017 Dec 12. pii: S1474-4422(17)30437.
    PubMed     Text format    


    Mov Disord

  12. ROOSEN DA, Singleton AB
    Leucine rich repeat kinase knockout (LRRK KO) mouse model: Linking pathological hallmarks of inherited and sporadic Parkinson's disease.
    Mov Disord. 2017 Dec 19. doi: 10.1002/mds.27267.
    PubMed     Text format    

  13. BOUTHOUR W, Wegrzyk J, Momjian S, Peron J, et al
    Short pulse width in subthalamic stimulation in Parkinson's disease: a randomized, double-blind study.
    Mov Disord. 2017 Dec 21. doi: 10.1002/mds.27265.
    PubMed     Text format     Abstract available

  14. LIU Z, Tang B
    Novel Parkinson's disease risk loci identified through a meta-analysis of genome-wide association studies.
    Mov Disord. 2017 Dec 21. doi: 10.1002/mds.27276.
    PubMed     Text format    

  15. BOWER JH, Grossardt BR, Rocca WA, Savica R, et al
    Prevalence of and indications for antipsychotic use in Parkinson's disease.
    Mov Disord. 2017 Dec 26. doi: 10.1002/mds.27256.
    PubMed     Text format     Abstract available

  16. MARRINAN SL, Otiker T, Vasist LS, Gibson RA, et al
    A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.
    Mov Disord. 2017 Dec 26. doi: 10.1002/mds.27259.
    PubMed     Text format     Abstract available

  17. MEROLA A, Romagnolo A, Rosso M, Suri R, et al
    Autonomic dysfunction in Parkinson's disease: A prospective cohort study.
    Mov Disord. 2017 Dec 26. doi: 10.1002/mds.27268.
    PubMed     Text format     Abstract available


    Nat Neurosci

  18. ROY S
    Author Correction: Synuclein and dopamine: the Bonnie and Clyde of Parkinson's disease.
    Nat Neurosci. 2017 Dec 20. pii: 10.1038/s41593-017-0035.
    PubMed     Text format     Abstract available


    Neurology

  19. BARTHEL C, Nonnekes J, van Helvert M, Haan R, et al
    The laser shoes: A new ambulatory device to alleviate freezing of gait in Parkinson disease.
    Neurology. 2017 Dec 20. pii: WNL.0000000000004795.
    PubMed     Text format     Abstract available

  20. ROSSO AL, Bohnen NI, Launer LJ, Aizenstein HJ, et al
    Vascular and dopaminergic contributors to mild parkinsonian signs in older adults.
    Neurology. 2017 Dec 15. pii: WNL.0000000000004842.
    PubMed     Text format     Abstract available


    Neurosci Lett

  21. HARRISON IF, Smith AD, Dexter DT
    Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
    Neurosci Lett. 2017;666:48-57.
    PubMed     Text format     Abstract available

  22. CHENG Y, Mao CY, Liu YT, Li F, et al
    Analysis of variant rs3794087 in SLC1A2 and Parkinson's disease in a Chinese Han population: a case-control study and meta-analysis.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31018.
    PubMed     Text format     Abstract available

  23. WANG L, Nie K, Zhao X, Feng S, et al
    Characteristics of gray matter morphological change in Parkinson's disease patients with semantic abstract reasoning deficits.
    Neurosci Lett. 2017 Dec 21. pii: S0304-3940(17)31020.
    PubMed     Text format     Abstract available


    PLoS One

  24. BARGIOTAS P, Eugster L, Oberholzer M, Debove I, et al
    Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    PLoS One. 2017;12:e0190027.
    PubMed     Text format     Abstract available

  25. BAJAJ S, Krismer F, Palma JA, Wenning GK, et al
    Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0189897.
    PubMed     Text format     Abstract available

  26. PINHO R, Guedes LC, Soreq L, Lobo PP, et al
    Correction: Gene Expression Differences in Peripheral Blood of Parkinson's Disease Patients with Distinct Progression Profiles.
    PLoS One. 2017;12:e0190552.
    PubMed     Text format     Abstract available

  27. ZHOU W, Barkow JC, Freed CR
    Running wheel exercise reduces alpha-synuclein aggregation and improves motor and cognitive function in a transgenic mouse model of Parkinson's disease.
    PLoS One. 2017;12:e0190160.
    PubMed     Text format     Abstract available

  28. NACKAERTS E, Broeder S, Pereira MP, Swinnen SP, et al
    Handwriting training in Parkinson's disease: A trade-off between size, speed and fluency.
    PLoS One. 2017;12:e0190223.
    PubMed     Text format     Abstract available

  29. SILVA DE LIMA AL, Hahn T, Evers LJW, de Vries NM, et al
    Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease.
    PLoS One. 2017;12:e0189161.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  30. WOERMAN AL, Kazmi SA, Patel S, Aoyagi A, et al
    Familial Parkinson's point mutation abolishes multiple system atrophy prion replication.
    Proc Natl Acad Sci U S A. 2017 Dec 26. pii: 1719369115.
    PubMed     Text format     Abstract available


    Rev Neurol

  31. TORRES CV, Lopez-Manzanares L, Navas-Garcia M, Pastor J, et al
    [Bilateral two-stage implantation for deep brain stimulation in the treatment of bilateral idiopathic Parkinson's disease: clinical outcomes].
    Rev Neurol. 2018;66:1-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: